Prosecution Insights
Last updated: October 02, 2026
Application No. 17/889,323

CATHETER ASSEMBLY

Non-Final OA §103
Filed
Aug 16, 2022
Priority
Feb 20, 2020 — JP 2020-026893 +1 more
Examiner
RITCHIE, HADEN MATTHEW
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Terumo Corporation
OA Round
2 (Non-Final)
73%
Grant Probability
Favorable
2-3
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allowance Rate
47 granted / 64 resolved
+3.4% vs TC avg
Strong +34% interview lift
Without
With
+33.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
26 currently pending
Career history
98
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
50.1%
+10.1% vs TC avg
§102
36.4%
-3.6% vs TC avg
§112
11.9%
-28.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 64 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment This office action is responsive to the amendment filed 06 January 2026. As directed by the amendment: claims 2 and 7-20 are cancelled, claims 5 and 6 are withdrawn. Claims 1 and 3-6 are presently pending. Response to Arguments Applicant’s arguments, see pages 4-6, filed 06 January 2026, with respect to the rejection(s) of claim(s) 1 under 35 USC 102 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of Ishida (US 2018/0207406) in view of Ishida (hereinafter “Ishida ’63”, US 2018/0280663). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1, 3 and 4 are rejected under 35 U.S.C. 103 as being unpatentable over Ishida (US 2018/0207406) in view of Ishida (hereinafter “Ishida ’63”, US 2018/0280663). Regarding claim 1, Ishida discloses a catheter assembly (Fig. 1, 10A) comprising: a catheter (Fig. 1, 12); a catheter hub (Fig. 1, 18) fixed to the catheter (12); an inner needle (Fig. 1, 20) inserted through the catheter (12); a grip (Fig. 1, 41 & 42) that fixes and holds the inner needle (¶[0102]); a catheter operation member (Fig. 2, 24) comprising an upper support portion (Fig. 2, 54) that supports the catheter from an upper side (¶[0112]); and a lower support member (Fig. 2, 22) that is attached to grip and supports the catheter from a lower side (¶[0100], [0106]-[0109]); wherein: the upper support portion comprises: a base portion in contact with an outer peripheral surface of the catheter (Fig. 2, where the portion 54 has a bottom surface that contacts at least a part of the rest of the catheter 12), and Ishida does not specifically teach a pair of distal projection portions protruding from the base portion between which the catheter is located, wherein: the distal projection portions are distal of the lower support member, and in a direction in which the distal projection portions protrude from the base portion, a length by which each distal projection portion protrudes past the catheter is greater than a maximum dimension of the catheter Ishida ’63 teaches a catheter which includes a hub, supports and a needle. Ishida ’63 teaches at least a projection (Fig. 2, 24) that also has two smaller wings that connect to a catheter member (Fig. 2, 25). This projecting portion projects at least a length and attaching this to Ishida would be a simple addition to the device. Additionally, a second projection can be added without issue or changing the function of the device. The length of said projections is not clear from the limitation in claim so a projection that extend away from the device would satisfy at least some dimension requirement. The projection 24 from the device in Ishida ’63 would improve Ishida by helping for operating the device and would allow for the device to have detachable operation functions (¶[0068] & [0105] from Ishida ‘63). Therefore it would have been obvious to one of ordinary skill in the art prior to the effective filing date of the claimed invention to modify the device of Ishida to have projections that extend at least a length from the catheter in a direction (Fig. 2, 24, ¶[0068] & [0105] from Ishida ’63). Regarding claim 3, Ishida and Ishida ’63 teach the catheter assembly according to claim 1, Ishida further teaches wherein: at least one of the upper support portion or the lower support member is deformed in a direction in which the upper support portion and the lower support member are aligned with each other (¶[0101], where the housing space has sidewalls 34a and 34b that extend upwards with 43 to contact and align with 24). Regarding claim 4, Ishida and Ishida ‘63 the catheter assembly according to claim 1, Ishida further teaches wherein: the upper support portion of the lower support member includes an elastic portion that is elastically deformed in a contact state with the catheter (¶[0100], holding portion 36). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to HADEN M RITCHIE whose telephone number is (703)756-1699. The examiner can normally be reached M-F 8am-5:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bhisma Mehta can be reached at 571-272-3383. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /HADEN MATTHEW RITCHIE/ Examiner, Art Unit 3783 /BHISMA MEHTA/Supervisory Patent Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Aug 16, 2022
Application Filed
Sep 16, 2025
Non-Final Rejection mailed — §103
Dec 17, 2025
Examiner Interview Summary
Jan 06, 2026
Response Filed
May 15, 2026
Final Rejection mailed — §103
Aug 17, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12714785
TECHNIQUES FOR IMPROVED AUTOMATIC DRUG DELIVERY PERFORMANCE USING DELIVERY TENDENCIES FROM PAST DELIVERY HISTORY AND USE PATTERNS
5y 8m to grant Granted Aug 25, 2026
Patent 12702509
STERILE PACKAGING ASSEMBLY FOR ROBOTIC INTERVENTIONAL DEVICE
4y 8m to grant Granted Aug 11, 2026
Patent 12702761
LOCKOUT MECHANISM FOR DRUG DELIVERY DEVICE
4y 2m to grant Granted Aug 11, 2026
Patent 12697465
INJECTION MOLDED CANNULA SYSTEM
4y 11m to grant Granted Aug 04, 2026
Patent 12691218
Apparatus and Methods of Chemically-Powered Fluid Flow Systems
4y 4m to grant Granted Jul 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
73%
Grant Probability
99%
With Interview (+33.8%)
3y 7m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 64 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month